Geerling, Clara F. http://orcid.org/0000-0001-9733-3458
Terheyden, Jan H. http://orcid.org/0000-0002-0174-4066
Langner, S. Magdalena
Kindler, Christine
Keil, Vera C.
Turski, Christopher A.
Turski, Gabrielle N.
Wintergerst, Maximillian W. M.
Petzold, Gabor C.
Finger, Robert P.
Funding for this research was provided by:
Rheinische Friedrich-Wilhelms-Universität Bonn
Article History
Received: 17 June 2021
Accepted: 21 February 2022
First Online: 7 March 2022
Competing interests
: CFG, JHT, SML, CAT, GNT: Heidelberg Engineering, Optos, Carl Zeiss Meditec, CenterVue (devices). CK, VCK: none. MWMW: Heidelberg Engineering, Optos, Carl Zeiss Meditec, CenterVue (devices), DigiSight Technologies (travel support) Heine Optotechnik (research funding), Heine Optotechnik (research funding, devices, travel reimbursement, consultant), D-EYE Srl (devices), Eyenuk Inc. (free analysis), ASKIN & CO GmbH (travel reimbursement, honoraria), Berlin-Chemie AG (grant, travel reimbursements). GCP: Bayer, Boehringer, Pfizer und BMS (sponsoring). RPF: Bayer, Novartis, Santen, Opthea, Novelion, Santhera, Inositec, Alimera and RetinaImplant, Allergan, Boehringer Ingelheim (consultant); Bayer, Ellex, Alimera (research funding); Heidelberg Engineering, Optos, Carl Zeiss Meditec, CenterVue (devices).